Results 61 to 70 of about 5,207 (190)
Pharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.Long‐term proton pump inhibitor (PPI) therapy raises significant concerns regarding cost‐effectiveness and adverse effects, necessitating effective deprescribing strategies. An evaluation of 763 Southeast Asian healthcare providers revealed two distinct prescriber phenotypes, where a proactive cluster utilized diverse, guideline‐based rationalization ...
Duc Trong Quach +15 more
wiley +1 more source
Prevalence of Barrett's esophagus in Lebanon
The Turkish Journal of Gastroenterology, 2015 Background/Aims: To determine the prevalence of Barrett’s Esophagus (BE) in a tertiary care center in Lebanon and to compare IT with regional and global data.
Omar Masri +4 more
doaj +1 more source
United European Gastroenterology Journal, Volume 14, Issue 5, June 2026.ABSTRACT Background Esophageal adenocarcinoma (EAC) represents one of the most increasing malignancies in Western countries. The disease is multifactorial, involving modifiable risk factors and genetic susceptibility variants. These variants can be aggregated to a polygenic risk score (PRS) that reflects individual genetic risk.
Vera Koch +24 more
wiley +1 more source
Confocal laser endomicroscopy for diagnosis of Barrett´s esophagus
Frontiers in Oncology, 2012 Barrett´s esophagus (BE) is established as a premalignant condition in the distal esophagus. Current surveillance guidelines recommend random biopsies every 1-2 cm at intervals of 3-5 years.
Helmut eNeumann +3 more
doaj +1 more source
Biomarkers of Barrett's esophagus
World Journal of Gastrointestinal Pathophysiology, 2014 Barrett's esophagus is the strongest risk for esophageal adenocarcinoma (EAC). Metaplasia in patients with BE may progress to dysplasia and then invasive carcinoma. Well-defined diagnostic, progressive, predictive, and prognostic biomarkers are needed to identify the presence of the disease, estimate the risk of malignant transformation, and predict ...
Yasser Mahrous, Fouad +3 more
openaire +2 more sources
How to Define the Gastroesophageal Junction
Digestive Endoscopy, Volume 38, Issue 6, June 2026.ABSTRACT Adenocarcinomas at the gastroesophageal junction (GEJ) are increasingly common worldwide. Current classifications, such as Siewert type II and Nishi, provide a foundation, but establishing a transparent and widely accepted framework could considerably enhance identification and treatment efforts.
Ken‐ichi Mukaisho +6 more
wiley +1 more source
Histopathology, Volume 88, Issue 7, Page 1295-1314, June 2026.Changes and new entities in the 6th edition WCT of the digestive system, including structural, molecular, and diagnostic updates to standardize terminology and improve clinical relevance. Epithelial tumours are organized by site; neuroendocrine, mesenchymal and haematolymphoid tumours have dedicated chapters, with refined grading, redefined ...
Mark J Arends +48 more
wiley +1 more source
Revista do Colégio Brasileiro de CirurgiõesOBJETIVO: Definir qual a melhor potência a ser empregada de forma a atingir a profundidade necessária para ablação com o menor número de sintomas pós-procedimento.
Vanessa Puccinelli Dotti +5 more
doaj +1 more source
Human papillomavirus‐associated adenoma of the anorectum
Histopathology, Volume 88, Issue 7, Page 1459-1463, June 2026.Aims Human papillomavirus (HPV) is the most common sexually transmitted disease in the United States. HPV‐associated invasive anorectal adenocarcinoma has been previously described. In this study, we report the clinicopathological features of three HPV‐associated anorectal adenomas.
Paula Toro +3 more
wiley +1 more source